Literature DB >> 7911873

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.

B Zöller1, B Dahlbäck.   

Abstract

Resistance to activated protein C (APC) is a major cause of familial thrombophilia, and can be corrected by an anticoagulant activity expressed by purified factor V. We investigated linkage between APC resistance and the factor V gene in a large kindred with familial thrombophilia. Restriction fragment length polymorphisms in exon 13 of the factor V gene were informative in 14 family members. The 100% linkage between factor V gene polymorphism and APC resistance strongly suggested a factor V gene mutation as a cause of APC resistance. A point mutation changing Arg506 in the APC cleavage site to a Gln was found in APC resistant individuals. These results suggest factor V gene mutation to be the most common genetic cause of thrombophilia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911873     DOI: 10.1016/s0140-6736(94)92940-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  Rapid detection of the factor V Leiden (1691 G > A) and haemochromatosis (845 G > A) mutation by fluorescence resonance energy transfer (FRET) and real time PCR.

Authors:  S H Neoh; M J Brisco; F A Firgaira; K J Trainor; D R Turner; A A Morley
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

2.  SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling.

Authors:  Qiang Wang; Adrian A Canutescu; Roland L Dunbrack
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Retinal arterial occlusion associated with resistance to activated protein C.

Authors:  S Vignes; B Wechsler; C Elmaleh; N Cassoux; M H Horellou; P Godeau
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

4.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

5.  Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.

Authors:  Amina Valjevac; Bakir Mehić; Emina Kiseljaković; Slavka Ibrulj; Agnieszka Garstka; Grażyna Adler
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

6.  Activated protein C resistance in patients with central retinal vein occlusion.

Authors:  J Larsson; A Sellman; B Bauer
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

7.  Primary Thrombophilia in México XI: Activated Protein C Resistance Phenotypes are Multifactorial.

Authors:  Ma Fernanda Vallejo-Villalobos; Andrés León-Peña; Mónica León-González; Ana Karen Núñez-Cortés; Juan Carlos Olivares-Gazca; Patricia Valdés-Tapia; Javier Garcés-Eisele; Alejandro Ruiz-Argüelles; Guillermo J Ruiz-Argüelles
Journal:  Indian J Hematol Blood Transfus       Date:  2016-12-19       Impact factor: 0.900

Review 8.  The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.

Authors:  Ilona Kopyta; Beata Sarecka-Hujar; Joanna Sordyl; Ryszard Sordyl
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

9.  Thrombophilia and damage of kidney during pregnancy.

Authors:  Larciprete Giovanni; Liumbruno Giancarlo Maria; Rongioletti Mauro; Montagnoli Carlotta; Rossi Federica; Papa Fabrizio; Jarvis Sheba; Di Pierro Giuseppe; Bompiani Alessandro; Cirese Elio; Valensise Herbert
Journal:  J Prenat Med       Date:  2011-10

10.  Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland.

Authors:  D J M Bowler; E Bale; J O'Byrne
Journal:  Ir J Med Sci       Date:  2007-10-23       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.